Cargando…

Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy

Over the last couple of years, the number of original papers and reviews discussing various applications of cell penetrating peptides (CPPs) has grown exponentially. This is not remarkable since CPPs are capable of transporting the most varying cargo across cell membranes which is one of the biggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Kersemans, Veerle, Cornelissen, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033971/
https://www.ncbi.nlm.nih.gov/pubmed/27713270
http://dx.doi.org/10.3390/ph3030600
_version_ 1782317907174227968
author Kersemans, Veerle
Cornelissen, Bart
author_facet Kersemans, Veerle
Cornelissen, Bart
author_sort Kersemans, Veerle
collection PubMed
description Over the last couple of years, the number of original papers and reviews discussing various applications of cell penetrating peptides (CPPs) has grown exponentially. This is not remarkable since CPPs are capable of transporting the most varying cargo across cell membranes which is one of the biggest problems in drug delivery and targeted therapy. In this review, we focus on the use of CPPs and related peptides for delivery of imaging contrast agents and radionuclides to cells and tissues with the ultimate goal of in vivo molecular imaging and molecular radiotherapy of intracellular and even intranuclear targets.
format Online
Article
Text
id pubmed-4033971
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-40339712014-05-27 Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy Kersemans, Veerle Cornelissen, Bart Pharmaceuticals (Basel) Review Over the last couple of years, the number of original papers and reviews discussing various applications of cell penetrating peptides (CPPs) has grown exponentially. This is not remarkable since CPPs are capable of transporting the most varying cargo across cell membranes which is one of the biggest problems in drug delivery and targeted therapy. In this review, we focus on the use of CPPs and related peptides for delivery of imaging contrast agents and radionuclides to cells and tissues with the ultimate goal of in vivo molecular imaging and molecular radiotherapy of intracellular and even intranuclear targets. Molecular Diversity Preservation International 2010-03-11 /pmc/articles/PMC4033971/ /pubmed/27713270 http://dx.doi.org/10.3390/ph3030600 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Kersemans, Veerle
Cornelissen, Bart
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
title Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
title_full Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
title_fullStr Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
title_full_unstemmed Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
title_short Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
title_sort targeting the tumour: cell penetrating peptides for molecular imaging and radiotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033971/
https://www.ncbi.nlm.nih.gov/pubmed/27713270
http://dx.doi.org/10.3390/ph3030600
work_keys_str_mv AT kersemansveerle targetingthetumourcellpenetratingpeptidesformolecularimagingandradiotherapy
AT cornelissenbart targetingthetumourcellpenetratingpeptidesformolecularimagingandradiotherapy